Active

Axepharma

Switched

BE0739549477

Rechtspersoon Private limited company 1 establishment

Beverhoutsveldstraat 64, 8730 Beernem Detailhandel in farmaceutische producten

Active for

6 year, 8 months

Financials

Financial year 2025

Gross margin

€ 151,840

▲ 5% vs 2024

Profit

Growing

€ 65,629

▲ 13% vs 2024

Debts

Low

€ 131,999

▲ 67% vs 2024

Axepharma from Beernem, company number BE0739549477, closed financial year 2025 with a result of € 65,629 after tax. For that financial year Axepharma recorded a gross margin of € 151,840 and equity of € 310,130. Compared with financial year 2024, the result moved from € 58,188 to € 65,629. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What happened at Axepharma?

What happened at Axepharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 65,629 (▲ 13% vs 2024). Source: NBB ↗
  • Wendy Vandenbussche became a director. NBB
  • New establishment in Brugge. KBO
  • Start of the company according to the CBE. KBO
  • Koen Thenaers became a director. NBB

In short

From € 67,606 profit in 2021 to € 65,629 profit in 2025.

Paid € 112,249 in corporate taxes since 2021.

Best year ever: 2022, with € 69,445 profit.

On average € 138,000 of value added per employee in 2025.

A new publication or filing at Axepharma? We notify you, reason included.

Follow Axepharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Koen Thenaers
Wendy Vandenbussche
Axepharma

Behind Axepharma are Koen Thenaers and Wendy Vandenbussche. The same people are also behind PLUS-VALUES.

See the full network in the app

Directors

According to the 2025 annual accounts

Koen Thenaers

Director

Also active at: PLUS-VALUES

since 2019

Wendy Vandenbussche

Director

Also active at: PLUS-VALUES

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Beverhoutsveldstraat 64

8730 Beernem

2.296.535.970

Smedenstraat 73

8000 Brugge

Active since 12 December 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0739.549.477
VAT number
BE 0739.549.477
Registered office
Beverhoutsveldstraat 64, 8730 Beernem
Names & denominations
Axepharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
12 December 2019
Peppol
Active · Active since 8 Nov 2024
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of Axepharma?
The enterprise number of Axepharma is BE0739549477.
What is the address of Axepharma?
The registered office of Axepharma is located at Beverhoutsveldstraat 64, 8730 Beernem.
When was Axepharma founded?
Axepharma was founded on 12 December 2019.
What is the main activity of Axepharma?
The main activity of Axepharma is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does Axepharma have a website?
No website is currently known for Axepharma.
How much profit did Axepharma make in 2025?
Axepharma posted a profit after taxes of € 65,629 in financial year 2025.
What is the revenue of Axepharma?
As a small company, Axepharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 151,840.
How many employees does Axepharma have?
According to the 2025 annual accounts, Axepharma has 1.1 full-time equivalents (FTE).
Where can I find the annual accounts of Axepharma?
Axepharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Axepharma?
According to the 2025 annual accounts, the directors of Axepharma are: Koen Thenaers, Wendy Vandenbussche.
Who owns Axepharma?
Behind Axepharma are Koen Thenaers and Wendy Vandenbussche. The same people are also behind PLUS-VALUES.